Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Enhancing lipid nanoparticles-mediated RNA delivery to glioblastoma via targeted strategies.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 24, 2025
Structurally-defined non-cationic docosahexaenoic acid based siRNA-micelles for safe and effective combinatorial glioblastoma therapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 16, 2025
Clinical translation of nanomedicines for brain diseases: Current challenges and future directions.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 07, 2025
Non-cationic carriers for siRNA delivery: Current progress and potential applications.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 31, 2025
Advanced nanoparticle engineering for precision therapeutics of brain diseases.
Journal: Biomaterials
Published: September 18, 2024
Stimuli-Responsive Polymeric Nanocarriers Accelerate On-Demand Drug Release to Combat Glioblastoma.
Journal: Biomacromolecules
Published: September 11, 2024
PEG length effect of peptide-functional liposome for blood brain barrier (BBB) penetration and brain targeting.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 04, 2024
Brain-Targeted Cas12a Ribonucleoprotein Nanocapsules Enable Synergetic Gene Co-Editing Leading to Potent Inhibition of Orthotopic Glioblastoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 29, 2024
Brain-targeted CRISPR/Cas9 nanomedicine for effective glioblastoma therapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 14, 2022
Last Updated: 09/26/2026